Login
EN
[EN] English
[FR] Français
Login
EN
[EN] English
[FR] Français
Give us feedback
Explore
Search
Special collections
Statistics
News
Help
Start on ORBi
Deposit
Profile
Publication List
Add your ORCID
Tutorials
Legal Information
Training sessions
About
What's ORBi ?
Impact and visibility
Around ORBi
About statistics
About metrics
OAI-PMH
ORBi team
Release Notes
Back
Home
Detailled Reference
Request a copy
Communication in media (Diverse speeches and writings)
Covid : pourquoi il ne faut pas brûler le tocilizumab ?
MALAISE, Olivier
;
LAYIOS, Nathalie
2018
Permalink
https://hdl.handle.net/2268/289959
Files (1)
Send to
Details
Statistics
Bibliography
Similar publications
Files
Full Text
tocilizumab contre covid CHU Liège JdM 5 novembre 2020 V2.docx
Author postprint (18.11 kB)
Request a copy
All documents in ORBi are protected by a
user license
.
Send to
RIS
BibTex
APA
Chicago
Permalink
X
Linkedin
copy to clipboard
copied
Details
Disciplines :
Rheumatology
Author, co-author :
MALAISE, Olivier
;
Centre Hospitalier Universitaire de Liège - CHU > > Service de rhumatologie
LAYIOS, Nathalie
;
Centre Hospitalier Universitaire de Liège - CHU > > Service des soins intensifs
Language :
French
Title :
Covid : pourquoi il ne faut pas brûler le tocilizumab ?
Publication date :
18 November 2018
Publisher :
Journal du Médecin
Available on ORBi :
since 26 April 2022
Statistics
Number of views
63 (13 by ULiège)
Number of downloads
4 (4 by ULiège)
More statistics
Bibliography
Similar publications
Contact ORBi